Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion type Assertion NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_head.
- NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion description "[Because little is known about CD44 in human hepatocellular carcinoma (HCC), we investigated its expression in tissue specimens from primary lesions (12 cases), in smear specimens from peritoneal effusions (2 cases), and in cell lines (HCC cell lines, KIM-1, KYN-1, KYN-2, KYN-3, HAK-1A, and HAK-1B; combined hepatocholangiocarcinoma cell lines, KMCH-1 and KMCH-2; and bile duct carcinoma cell lines, KMC-1 and KMBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_provenance.
- NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion evidence source_evidence_literature NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_provenance.
- NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion SIO_000772 7537711 NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_provenance.
- NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion wasDerivedFrom befree-2016 NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_provenance.
- NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_assertion wasGeneratedBy ECO_0000203 NP1311369.RAfRlZIF-kfG2o_Gs3zbIGP4yhmHemtjy8ViV92R-PsUc130_provenance.